Allied to this will be the first of many Phase III trials with adaptive design in CRC, which will enable the ... Good evidence exists for the use of anti-EGF receptor (EGFR) monoclonal antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback